USPTO 2015–2025 USPTO PatentsView US Corporation

H. LEE Moffitt Cancer Center AND Research Institute Inc.

USPTO PatentsView assignee record - 247 granted patents across 34 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, H. ranks #1,664 of 49,997 tracked US assignees by granted-patent volume, with 247 patents across 34 technology areas.

#1,664
of 49,997 US assignees by volume
Top 8%
by Innovation Score (53.9/100)
14.4
avg claims per patent
+26%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1664 · US Corporation #1,664 · 247 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MID 247 grants
  • TOP-DECILE #1,664/49,997
  • PHOTO-FINISH Biogen MA
  • CPC-FOCUS A61K · 34 areas
  • INNOV-PAR 53.9/100
  • CLAIMS-RICH 14.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +26% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Biogen MA Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around H.

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows H.'s Innovation Score is 53.9/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where H.'s grants concentrate

H. LEE Moffitt Cancer Center AND Research Institute Inc. is a focused PatentsView assignee: 34 CPC subclasses with 58.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (39 grants) versus a trough of 10 in 2015. By volume, H. sits between Teradata US, Inc. and Saint-gobain Ceramics & Plastics, Inc..

H.'s three-year grant acceleration

From 2019–2021 to 2022–2024, H. LEE Moffitt Cancer Center AND Research Institute Inc. moved from 89 to 74 grants (0.83x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,716. See the growth leaderboard.

Who files at H's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows H. holds 247 patents at rank #1,664, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near H

By rank, the assignees closest to #1,664 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in H's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for H, neither rank-band nor same-CPC leaders (those blocks stay above).

H.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

01020304050 20152016201720182019202020212022202320242025 16
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
H. LEE Moffitt Cancer Center AND Research Institute Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 10 4.0%
2016 15 6.1%
2017 20 8.1%
2018 23 9.3%
2019 34 13.8%
2020 39 15.8%
2021 16 6.5%
2022 27 10.9%
2023 17 6.9%
2024 30 12.1%
2025partial year 16 6.5%

Which technologies does H. LEE Moffitt Cancer Center AND Research Institute Inc. patent most?

Top 15 of 34 technology areas

Where it ranks

Overall rank by patents

#1,664

of 49,997 tracked assignees

Innovation Score

53.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

H. LEE Moffitt Cancer Center AND Research Institute Inc.'s patent record in context - here's where to go next.

  • H. LEE Moffitt Cancer Center AND Research Institute Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 58.7% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #1,664 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare H. LEE Moffitt Cancer Center AND Research Institute Inc. against Teradata US, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.